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Abstract: While implant-related infections continue to play a relevant role in failure of implantable
biomaterials in orthopaedic and trauma there is a lack of standardised microbiological procedures to
identify the pathogen(s). The microbiological diagnosis of implant-related infections is challenging
due to the following factors: the presence of bacterial biofilm(s), often associated with slow-growing
microorganisms, low bacterial loads, previous antibiotic treatments and, possible intra-operative
contamination. Therefore, diagnosis requires a specific set of procedures. Based on the Guidelines
of the Italian Association of the Clinical Microbiologists (AMCLI), the World Association against
Infection in Orthopaedics and Trauma has drafted the present document. This document includes
guidance on the basic principles for sampling and processing for implant-related infections based
on the most relevant literature. These procedures outline the main microbiological approaches,
including sampling and processing methodologies for diagnostic assessment and confirmation of
implant-related infections. Biofilm dislodgement techniques, incubation time and the role of molecular
approaches are addressed in specific sections. The aim of this paper is to ensure a standardised
approach to the main microbiological methods for implant-related infections, as well as to promote
multidisciplinary collaboration between clinicians and microbiologists.
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1. Introduction
Periprosthetic joint infection (PJI) remains a serious complication in orthopaedic surgery. The
infection rate after primary knee or hip replacement is estimated to range between 0.3 and 1.9% [1],
and may exceed 10% in revision surgery or in patients with specific risk factors [2]. Similarly, the
incidence of infection after internal osteosynthesis (intramedullary nails, plates, screws, etc.) ranges
from 1 to 2% for closed fractures to over 30% for the open fractures.
Pathogen identification through microbiological analysis of samples is pivotal to confirm the
diagnosis of PJI. Microbiological findings are a common criteria incorporated into definitions of PJI
and diagnostic algorithms, including the definition recently released by the World Association against
Infection in Orthopaedics and Trauma (WAIOT) (Tables 1 and 2) [3–5].
The microbiological diagnosis plays a central role in infection confirmation, and also is critical for
determining antimicrobial susceptibility of the pathogen(s) to guide the antimicrobial treatment.
Microbiological diagnosis of implant-related infection has unique aspects that may make it
extremely challenging. Firstly, the presence of bacterial biofilms in virtually all implant-related
infections, and especially in chronic infections, coupled with the ability of the microorganisms to
persist in a slow-growing or even intra-cellular state, markedly reduce the sensitivity of traditional
microbiological culture techniques for pathogen(s) detection and identification. The presence of
biofilms plays a role in “acute” and “chronic” clinical presentations. Biofilm formation is known to
occur in few hours after bacterial adhesion on a surface. The clinical features of acute, subacute and
chronic infections are related to the host’s response and to the interaction between the bacteria and
the host. The age and maturity of the biofilm is an important factor influencing diagnostic yields: in
established, “chronic” infections, lower sensitivity of diagnostic tests is noted. This may relate to low
bacterial loads, slow-growing states and prior antibiotic exposure [6,7]. Added to these challenges,
microbiological sampling undertaken during complex and prolonged surgical procedures, may lead to
bacterial contamination of the specimens and false positive results.
Despite of the key role of microbiology culture techniques to diagnose these complex
implant-related infections in orthopaedics and trauma, there is a universal lack of standardized and
shared procedures for microbiological sampling and processing. According to a recent survey conducted
in twenty leading orthopaedic centres, a remarkably heterogeneous spectrum of microbiological
procedures was reported across the world [7]. This impacts on the overall diagnostic accuracy and
reproducibility of the results and has prompted the World Association against Infection in Orthopaedics
and Trauma to draft the present document, based on the Guidelines of the Italian Association of the
Clinical Microbiologists (AMCLI) released in 2013 and revised in 2017, on “Microbiological Sampling
and Processing of Implant-Related infections” [8].
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Table 1. The key role played by the microbiological diagnosis (highlighted in bold) in the most commonly adopted peri-prosthetic joint infection (PJI) definitions,
published from 2011 to 2018 [9]. Muscoloskeletal Infection Society (MSIS); Infectious Diseases Society of America (IDSA); International Consensus Meeting (ICM);
European Bone and Joint Society (EBJIS).
Definition Source MSIS 2011 [1] IDSA 2013 [2] ICM 2013 [3] ICM 2018 [4] Proposed EBJIS 2018 [5]
Scoring system 1 of the 2 Major Criteria
OR
≥4 of 6 Minor Criteria *
≥1 Positive Criteria * 1 of the 2 Major Criteria
OR
≥3 of 5 Minor Criteria *
1 of the 2 Major Criteria
OR
Minor criteria scoring ≥6 Infected
3–5 Possibly infected
(“Consider further molecular diagnostics
such as next-generation sequencing”)
<3 Not infected *
≥1 Positive Criteria
* “PJI may be present if fewer than
four of these criteria are met”
* “The presence of PJI is possible
even if the above criteria are not
met ( . . . )”
* “PJI may be present without
meeting these criteria, ( . . . ).”
* “Proceed with caution in adverse local
tissue reaction, crystal deposition disease,
slow growing organisms”
Criteria Major:
1. Sinus tract communicating
with the prosthesis;
2. A pathogen is isolated by
culture from at least two
separate tissue or fluid
samples obtained from the
affected prosthetic joint
Minor:
(a) Elevated ESR (>30 mm/h)
and CRP (>10
mg/L) concentration
(b) Elevated synovial
leukocyte count
(c) Elevated PMN%
(d) Purulence in the affected joint
(e) Isolation of a
microorganism in one
culture of periprosthetic
tissue or fluid
(f) Greater than five neutrophils
per high-power field in five
high-power fields observed
from histologic analysis of
periprosthetic tissue at
×400 magnification
1 Sinus tract communicating
with the prosthesis
2 Purulence without other
etiology surrounding
the prosthesis
3 Acute inflammation seen on
histopathological
examination of the
periprosthetic tissue
4. ≥2 intraoperative cultures or
combination of preoperative
aspiration and
intraoperative cultures
yielding an indis
tinguishable organism (the
growth of a virulent
microorganism (e.g.,
Staphylococcus aureus) in a
single specimen of a tissue
biopsy or synovial fluid is
also considered as
indicative of a PJI)
Major
1. A sinus tract
communicating with
the joint
2. Two positive
periprosthetic cultures
with phenotypically
identical organisms,
Minor:
(a) Elevated ESR (>30 mm/h)
and CRP (>100 mg/L for
acute infections; >10 mg/L
for chronic infections)
(b) Elevated synovial fluid
WBC count (>10,000
cells/mL for acute infections;
>3000 cells/mL for chronic
infections) or ++ change on
leukocyte esterase test strip
(c) Elevated PMN% (>90% for
acute infections; >80% for
chronic infections)
(d) Positive histological
analysis of periprosthetic
tissue (>5 neutrophils per
high-power field in five
high-power fields observed
on periprosthetic tissue at
×400 magnification)
(e) A single positive culture
Major:
1. Sinus tract with evidence of
communication to the joint or
visualisation of the prosthesis
2. Two positive growths of the same
organism using standard culture
methods
Minor:
(a) Elevated CRP (>100 mg/L for acute
infections; >10 mg/L for chronic
infections) or D-Dimer (unknown
threshold for acute infection; >860
µg/L for chronic infection) (score 2)
(b) Elevated ESR (no role for acute
infections; >30 mm/h for chronic
infections) (score 1)
(c) Elevated synovial WBC count
(>10,000 cells/mL for acute
infections; >3000 cells/mL for
chronic infections) OR Leukocyte
Esterase (++ for acute and chronic
infections) OR Positive
alpha-defensin (score 3)
(d) Elevated synovial PMN% (>90%
for acute infections; >70% for
chronic infections) (score 2)
(e) Single positive culture (score 2)
(f) Positive histology (score 3)
(g) Positive intraoperative purulence
(score 3)
1. Purulence around the prosthesis
or sinus tract
2. Increase synovial fluid leukocyte
count (>2000 cells/mL or
>70% granulocytes)
3. Positive histopathology
4. Confirmatory microbial growth
in synovial fluid, periprosthetic
tissue, or sonication culture
(“Confirmatory microbial growth in
periprosthetic tissue: if positive in ≥1
specimen in highly virulent
organisms or ≥2 in low virulent
pathogens; sonication culture
considered positive if >50
colony-forming units/mL of
sonication fluid.”)
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Table 2. The key role played by the microbiological diagnosis (highlighted in bold) in WAIOT definition
of peri-prosthetic joint infection (PJI), proposed in 2019 [5]. Biofilm-related implant malfunction (BIM).
Low-Grade PJI (LG-PJI). High-Grade PJI (HG-PJI).
No Infection Contamination BIM LG-PJI HG-PJI
Clinical presentation
One or more condition(s), other than infection,
can cause the symptoms or the reason for
reoperation (e.g., wear debris, metallosis,
recurrent dislocation or joint instability,
fracture, malposition, neuropathic pain)
One or more of the following:
otherwise “unexplained” pain,
swelling, stiffness
Two or more of the
following: pain,
swelling, redness,
warmth, functio
laesa
# of Positive Rule IN
minus
# of Negative Rule
OUT tests
<0 <0 <0 ≥0 ≥1
Post-operatively
confirmed if
Negative
cultural
examination
One pre- or
intra-operative positive
culture, with negative
histology
Positive cultural examination (preferably with
antibiofilm techniques) and/or positive histology
Abbreviations: WAIOT: World Association against Infection in Orthopedics and Trauma; BIM: Biofilm-related
Implant malfunction; LG-PJI: Low-Grade Peri-Prosthetic Joint Infection; HG-PJI: High-Grade Peri-Prosthetic
Joint Infection.
2. Microbiological Features and Actual Issues
Although still debated, PJIs can be diagnosed when at least one of the following criteria is present:
two positive cultures with microorganisms having identical phenotype, or the presence of a sinus tract
in communication with the prosthesis [3,4,9–12]. Alternatively, at least three of the following five minor
criteria can be satisfied to establish the diagnosis of PJI: high ESR and CRP [13–15]; elevated leukocytes
count in joint fluid [9,16,17]; “++” positive test of leukocyte esterase on a test strip performed on
joint fluid [18,19]; elevated percentage of neutrophils in joint fluid [9,16,17]; acute inflammation of
periprosthetic tissues at histological examination [20] and/or; a positive culture in a single sample.
Despite these criteria, there is a lack of an overall agreement between the different microbiological
laboratories and countries on optimal diagnostic approaches, reflecting limited collaboration between
Microbiologists and Orthopaedic surgeons.
The site of intraoperative periprosthetic tissue sampling influences the yield of microbiological
culture for periprosthetic joint infections. Bacteria can infect different sites of the prosthetic components
as well as in the tissues. The rate of positivity of samples differs when specimens are obtained from
tissues or fluids in contact with prosthetic material compared with cancellous bone [21]. However,
the rate of positivity is also dependent on the modality of collection, transportation and processing
of samples, as well as on the type of microorganism and the host’s response. The presence of
low-grade pathogens, such as coagulase-negative staphylococci, Enterococcus spp, Corynebacterium spp,
Cutibacterium acnes, can further impact the diagnostic yield when compared with highly pathogenic
microorganisms, such as Staphylococcus aureus. In the setting of a mature and established biofilm, many
common microbiological culture techniques may be falsely negative, further compounding laboratory
diagnostic challenges.
Staphylococci are the most frequently isolated microorganisms in both early and late infections [22].
Coagulase negative staphylococci, such as Staphyloccocus epidermidis, Staphyloccocus lugdunensis,
Staphyloccocus capitis, Staphyloccocus hominis, Staphyloccocus caprae are the most common organisms
isolated in PJIs (30–43%), followed by S. aureus (12–23%) [23–26]. Streptococci, enterococci and
diphtheroids are isolated in about 10% of cases, and gram-negative bacteria (Enterobacteriaceae and
Pseudomonas) in about 8% [25]. Among the anaerobic bacteria, Cutibacterium (former Propionibacterium)
acnes is the most frequent, while 10–12% of infections are caused by more than one microorganism [26]. In
the haematogenous infections, S. aureus and coagulase-negatives are the predominant microorganisms,
followed by Streptococcus spp and Gram-negative bacteria [27].
The infections related to the osteosynthesis devices are mainly caused by S. aureus, but are often
polymicrobial [28].
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Other microorganisms may be also involved after a direct inoculation or haematogenous spreading,
and the aetiology includes mycobacteria and fungi [29].
Often the diagnosis of infection is complicated by the failure of traditional microbiological culture
approaches to isolate the causative pathogen. This is due to the fact that microorganisms are organized
and embedded within complex structures, known as biofilms, which typically occur on the surface of
prosthetic material. These biofilm associated microorganisms are difficult to diagnose and treat [30].
The adhesion of microorganisms to prosthetic surfaces reduces their detection. An additional issue is
the presence of “small colonies variants”, a distinct bacterial phenotype that may occur in the microbial
sub-populations within the biofilm. The slow growth of this microbial variant may also increase the
time of detection and impacts clinical management outcomes.
Currently methods to evaluate the in vitro activity of antimicrobials against biofilm-associated
microorganisms are not routinely available in clinical laboratories [29].
3. Methodology
These procedures have been developed through systematic review of recent publications. An
electronic search of all available literature included the following search term “Microbiology procedures
for the diagnosis of Prosthetic Joint infections”.
The search included digital sources on PubMed (http://www.ncbi.nlm.nih.gov/pubmed/),
ScienceDirect (www.sciencedirect.com), Institute of Scientific Information (ISI) Web of Knowledge
(http://www.isiwebofknowledge.com) and Google Scholar (http://scholar.google.com). This review
also incorporates manual review of included publications on the website of the Italian Scientific Society
of Clinical Microbiology (AMCLI). Only peer-reviewed and highly impactful Journals were considered.
No typical microbiological methods or tests were excluded in this analysis.
The following sections summarize and critique microbiological issues along the diagnostic pathway,
from samples collection to culture processes and interpretation in the microbiology laboratory.
3.1. Microbiological Sampling
The culture and isolation of the microorganism is a major criterion for the diagnosis of prosthetic
joint infections. Samples suitable for microbiology testing are: periprosthetic tissues, joint fluid and/or,
prosthetic components removed during the revision procedure.
During the pre-operative phase, culture of joint fluid can aid diagnosis and is recommended [31].
Joint fluid collection should be performed by arthrocentesis and the microbiological culture of joint
fluid must include approaches to detect aerobic and anaerobic microorganisms (see below).
Blood cultures for aerobic and anaerobic microorganisms also may be performed, particularly in
patients with fever and/or acute onset of symptoms, or a concomitant infection that makes the presence
of bacteraemia highly probable, such as infective endocarditis [4,32].
Percutaneous biopsy of peri-implant tissues, preferably supported by ultrasound guidance or
other imaging systems, such as fluoroscopy, may be suitable for microbiological aerobic and anaerobic
cultures. In case of prosthetic loosening, the biopsy may be taken from the cement-bone interface or
around the prosthetic components. Collection of an additional periprosthetic tissue sample also may
be useful for histological examination [29]. In the intra-operative phase, microbiological investigations
should include cultures of joint fluid or of the joint capsule. Aerobic and anaerobic cultures must be
performed on periprosthetic tissue and joint fluid specimens. A minimum of four periprosthetic tissue
samples should be collected. Alternatively three periprosthetic tissue specimens maybe adequate if
the homogenate cultures are furtherly inoculated in blood culture bottles [33]. Retrieved prosthetic
components and/or osteosynthesis devices can be processed using specific methods, such as sonication,
to dislodge bacteria from the biofilms and the sonicate fluid should be cultured aerobically and
anaerobically. Samples of external fixators or any purulent material collected around the fixator pin
by a sterile syringe may be also collected. However, sampling of external fixator pin site in clinical
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setting has limited value, due to the risk of contamination of the specimen with skin flora. Therefore
this practice should be discouraged [11].
Guidance for intra-operative specimen processing, from the sample collection until the
microbiological report, is described below.
3.1.1. Sample Collection
The collection of synovial fluid is performed by percutaneous joint aspiration using aseptic
technique, and may be performed with ultrasound guidance, particularly for aspiration of the hip
joint. The fluids can be inoculated onto appropriate culture media or blood culture bottles (≥1ml per
bottle) for aerobic and anaerobic microorganisms [21,34,35]. The remaining aspirate should also be
transferred into sterile vials for subsequent cultures and in ethylenediaminetetraacetic acid (EDTA)
tubes for total leukocyte and polymorphonuclear neutrophil count. In osteosynthesis device infections
syringe aspiration of fluid collections in the area surrounding the implant may be helpful.
Intraoperatively, the collection of multiple biopsies is essential to increase the sensitivity of culture
methods and to distinguish contaminating microorganisms from pathogens. Each biopsy should be
collected using separate, sterile instruments. Periprosthetic fields should be explored and sampled,
with careful attention to avoid contact with the skin and other external materials of operative field [3,21].
Biopsy should then be inserted directly into sterile and hermetically sealed tubes or containers to
prevent any risk of contamination. Three to six biopsies should be collected [4]. In case of prosthetic
infections, the sampling should preferentially include biopsies from the implant-bone interface or from
the joint capsule or any areas with macroscopic signs of inflammation [21]. In case of osteosynthesis
devices infections, the samples should be collected from the peri-implant inflamed area. A volume
of approximately 1 cm3 for tissue biopsy samples is recommended to aid analysis, including the
histopathological examinations [20].
All the explanted prosthetic components (femoral stem, acetabular cup, femoral shield, tibial plate,
polyethylene insert, humeral stem, glenoid), the periprosthetic cement, or the osteosynthesis devices
(screws, plates, intramedullary nails) as well as the non-absorbable sutures or the bone substitutes,
are considered suitable samples for microbiological examination. The probability of finding bacteria
organized in their biofilms is very high in these samples. Particular attention must be paid during
the collection of prosthetic/biomaterial components to avoid contamination. Components should
be excluded in the event of direct contact with the patient’s skin during extraction/removal, or if
instruments used are suspected to have had direct contact with the skin. Components should be
transferred into a non-perforable, sterile, leak-proof container of suitable size, and care should be
taken to minimize further manipulation by the operators. The containers must be properly sealed and
sent to the laboratory as soon as possible. To increase the specificity of the culture each component
should be placed in a separate container [36]. If the components are to undergo sonication for
detachment of microorganisms organized in biofilm, it is advisable to cover the at least 90% volume of
the removed component with Ringer’s solution or sterile physiological solution, avoiding external
microbial contaminations [36–39]. It is also recommended to send an additional sterile, non-perforable
containers with or without Ringer’s solution or sterile physiological solution, to act as a negative
control for culture following the same procedures used for explanted prosthetic components [40].
3.1.2. Transportation
Transportation of samples to the laboratory must performed in a timely manner. Tissue samples
and prosthetic components should be stored at 4 ◦C if transport to the laboratory is delayed [29].
Blood cultures bottles inoculated with joint fluid can be stored at room temperature up to 48 h. To aid
communication, the following information should be included with the specimens: date and time of
collection, name of a contact person collecting the samples, anatomical site and any clinical information
(antibiotic therapy, previous infectious diseases), specifying any request for additional microbiological
tests (i.e. mycobacteria) [11].
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3.1.3. Swabs and Drainage fluids
Sinus tract swabs or secretions are not so suitable for cultures because isolated microorganisms
often represent the colonizing microbial skin flora. Organisms isolated from sinus tract swabs correlate
poorly with the etiologic agent responsible of a deep infection, with the only exception of S. aureus [26].
Swabs of peri-prosthetic materials should be avoided as the culture sensitivity is low, compared with
tissue samples or prosthetic components [41,42]. The preparation of cultures from drainage or drainage
liquids is also not recommended due to the high risk of contamination [11]. Similarly swabs of open
wounds are discouraged.
3.2. Microbiological Culture Approaches
3.2.1. Samples Handling and Incubation
The materials used to diagnose prosthetic or osteosynthesis device infections must be handled
in a class 2 biological cabinet. To minimize the possibility of contamination the number of times in
which the laboratory staff handle the samples or open containers should be limited [29]. The technician
must use disposable gloves (and replaced gloves during prolonged work). Specimen inoculation
and inspection for microbiological growth on culture media must be carried out under the same
conditions [11]. Culture methods include the use of solid agar plates as well as broth media for
enrichment [29,34]. Incubation should be a minimum of 5–7 days for aerobic cultures and up to 14
days for anaerobic culture methods. Prolonged incubation is recommended when chronic and delayed
infections due to slow-growing microorganisms and anaerobic bacteria, such as Cutibacterium acnes, are
suspected, for example with prosthetic shoulder joint infections [21,43–45]. Several studies in recent
years report the advantages of using blood culture bottles for culture of joint fluid, periprosthetic
tissue homogenate and sonication fluid from the prosthesis. The inoculation of blood culture bottles
allows continuous growth monitoring as well as the possibility of inoculating larger sample volumes
than solid media. The presence of antimicrobial removal systems and lytic agents in the blood bottles
promotes in addition the release of intracellular microorganisms [21,29,34,46–51]. By using blood
culture and semiautomatic monitoring systems, a reduced time to culture positivity has been observed,
when compared to conventional agar plates and broth methods [46,50,52]. The bottles should be
incubated for a minimum of 7 days for the aerobic bottle and 14 days for the anaerobic bottle [46,51,53].
A Spanish group experienced that extending incubation of the samples to 14 days does not add more
positive results for sonicated orthopaedic implants compared with a conventional seven-day incubation
period [54].
The use of blood cultures bottles for inoculation of joint fluids directly at the patient’s bedside,
during pre-operative or operative revision surgery, may also assist with the diagnosis of chronic
infections, or in patients exposed to antibiotic treatments prior to sampling [11,29].
In acute infections, a Gram stain of the joint aspirate can be also useful, although a negative result
does not exclude the possibility of infection [29]. In general, Gram staining has high specificity, but
low sensitivity (Sensitivity 26%, Specificity 97%) [55]. Cultures of tissues can be performed with sterile
solution 0.1% (w:v) of dithiothreitol or by homogenizing the biopsies in 3 ml of broth (i.e., Brain Heart
Infusion broth) in aseptic environment [56,57].
Literature suggests biopsies should undergo pre-treatment with homogenization. A number
of different approaches to homogenization exist [21,33,58–60]. However, anecdotal reports have
suggested challenges with the homogenization procedure, therefore vortexing may be used instead for
specimen preparation.
3.2.2. Sonication or Dithiothreitol (DTT) Biofilm Dislodging Procedures
Sonication improves the sensitivity of culture of prosthetic components or osteosynthesis
devices [39,57,61]. The containers with prosthetic components must be handled under a laminar
flow cabinet and covered to at least 90% of its volume with Ringer’s solution or sterile physiological
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solution. The samples are vortexed for 30 s, sonicated at 30-40 KHz 0.22 ± 0.04 W/cm2 for 5 min and
vortexed again for additional 30 s. These procedures must be performed with careful attention to
sterile technique to minimize possible contamination. Other authors include a further step of 5 min of
centrifugation to improve the detection and the sensitivity of sonication. Sonication may be also useful
in other specific conditions, such as pedicle screw loosening in spinal surgery and infection diagnosis
on megaprostheses [62,63]. Furthermore, even if limited evidence exists to date, sonication could be
used on cement spacers, when a persistent infection is suspected [64].
The use of a solution of dithiothreitol (DTT) may be used as an alternative to sonication [65]. In
this approach a sterile solution of 0.1% (w: v) of dithiothreitol (DTT, formula C4H10O2S2, molecular
weight: 154.2) in phosphate buffer saline (PBS) is added to cover the prosthetic components. The
container with prosthetic components and DTT solution is shaken up at about 80 rpm for 15 min.
The incubation approaches for aerobes and anaerobes are in keeping with the previously described
methods. A recent study found comparable results between DTT and sonication for the detection
of PJIs in 232 patients undergoing revision, and both approaches were more sensitive than standard
tissue cultures [66].
Each method used by the laboratory should be properly certified to ensure standard approaches
to microbiological culture and microorganism identification.
3.2.3. “Atypical and Rare” Microorganisms
Attention should be paid to the “small colonies variant” and to the microorganisms removed
from the biofilm as they may represent aberrant phenotypes which result from inactivation of specific
enzymatic processes. However, the repeated subcultures of these “small colony variants” in enriched
media often lead to these variants returning to their original phenotypic traits [67,68].
Microorganisms, such as Abiotrophia defectiva and Granulicatella adiacens (previously classified as a
nutritional variant of streptococci) are difficult to detect in culture. Additional cultures for fungi and
mycobacteria should be considered in patients with clinical evidences of prosthetic infection in whom
standard microbiological cultures are negative. Additional molecular tests may be performed to allow
detection and identification of non-culturable organisms (including antimicrobial affected organisms),
or serological tests for Brucella and Coxiella [69]. Infections caused by the so-called low-grade pathogen
still may be present in patients with no specific symptoms or sub-clinical signs (absence of fever,
negativity of inflammation or infection markers, absence of sinus tracts). In these cases, C-Reactive
Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) values may not to be markedly increased. In
patients with presumed aseptic failure of the prosthesis, dedicated molecular methods have resulted in
the detection of a microorganism in 4–13% of cases [70]. These detected pathogens are usually low
virulence organisms, and include coagulase-negative staphylococci, cutibacteria, corynebacteria. These
infections are typically characterised by the absence of host inflammatory responses and tissue damage
which decreases the diagnostic sensitivity of standard clinical evaluations or common laboratory
parameters [30]. In these sub-clinical infections, joint fluid cultures may be negative, therefore sample
processing assumes particular relevance to augment their detection [30,71,72].
3.2.4. Antimicrobials for Susceptibility Testing
The following antimicrobials may be tested in vitro according to the EUCAST guidelines (www.
eucast.org), guided by the type of bacterial identification: rifampicin, levofloxacin, moxifloxacin,
ciprofloxacin, daptomycin, teicoplanin, vancomycin, linezolid, minocycline, clindamycin, fusidic
acid, cotrimoxazole, amoxicillin/clavulanic acid, piperacillin-tazobactam, meropenem, ertapenem,
oxacillin, fosfomycin, 3rd generation cephalosporins (such as ceftriaxone), colistin and, tigecycline.
The Minimum Inhibitory Concentrations (MICs) should be reported.
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3.2.5. Molecular Methods
Culture remains the gold standard in the diagnosis of periprosthetic joint infections. Molecular
techniques have a role in some specific cases such as negative cultures with a strong suspicion of
infection, or in case of fastidious microorganisms [73,74]. Molecular techniques can confirm the
presence of microorganisms and provide their identification, but they do not give a full and exhaustive
antibiotic-sensitivity profile for all the antimicrobials indicated for PJIs therapy. The sensitivity of the
molecular tests is dependent on sample type [73,75–78]. At present, molecular tests have not been
fully incorporated into routine laboratory diagnostic protocols for PJI because of the high costs of
these tests and lack of data to support the superiority of polymerase chain reaction (PCR) compared
with traditional culture methods [79,80]. Recently studies examining multiplex-PCR or microarrays
have reported high specificity (greater than 95%) [81]. However, primers for the common PJI isolates
(such as Cutibacterium acnes may not be included in commercially available multiplex PCR kits [82].
Metagenomic shotgun sequencing may be another interesting tool for diagnosing prosthetic infections.
Ivy MI et al. demonstrated that this approach can detect pathogens involved in PJI when applied to
culture-negatives synovial fluids [83].
Therefore, ongoing research and development of non-cultural methods (microarray, next
generation sequencing) may realize improvements in sensitivity and diagnostic accuracy, as well as
shortening the detection time of pathogens, and standardizing and automating analytical procedures.
3.3. Reporting of Microbiological Results
Reporting an accurate diagnosis of infection in the setting of prostheses or fixation devices
requires an integrated approach between laboratory capabilities and the clinical results. This approach
could also help to define the potential etiological role of those microorganisms isolated from a single
tissue sample or prosthetic component [38]. The growth of a virulent microorganism, such as S.
aureus, Pseudomonas aeruginosa, Enterobacteriaceae, or anaerobic bacteria, in a single tissue biopsy or
prosthetic/joint fluid sample may be consistent with infection [4,21]. The growth of microorganisms,
such as coagulase-negative staphylococci and Cutibacterium acnes, from a single sample may not
be indicative of infection and may represent contamination of the specimen. The specific role of
the low-grade microorganisms should be evaluated by the clinician on the basis of clinical and
investigation findings [4]. These microorganisms should be reported as “Possible contaminating
microorganism: assess its clinical significance”. Microbiological reports should be performed with
timely communication of clinically significant positive cultures, and should contain the microorganism/s
identification and the relevant antibiotic susceptibility tests [29]. It may be of assistance to the clinicians
if the microbiology laboratory provides a preliminary report after 5 days of incubation, and a second
final report at the end of the incubation period.
The absence of growth from all tissues and/or prosthetic/joint fluid samples should be referred to
as: “Absence of growth”.
4. Conclusions
Given the complexity of prosthetic device infections, there are several critical aspects that influence
laboratory diagnosis. In particular, processing methods of the biological samples, as well as the
patient’s clinical information, if not addressed and carefully considered, may lead to an incorrect
or missed diagnosis, influencing patient and healthcare outcomes. Figure 1 summarizes the 10
recommendations/critical issues which should be followed for a correct diagnosis of PJIs and implant
related infections.
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first operator to other personnel before placing the samples in sterile containers [84]. Collection of 
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The isolation of one micro rganism in a single sample may still repres nt infection. The distinction
between pathogen and contamination is one of the most challenging steps in the diagnostic algorithm.
Consequently, the method of sample collection by the orthopaedic specialist i of p ramount importance
to avoid the risk contamination. Contamination of prosthetic and tissues samples potentially accounts
for 3% to 52% of false p sitive results [78]. The main sources of contaminating microorganisms include
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direct (operating b d) insertion of biological materials in a suitable sterile containers significantly
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outside the surgical field, or transferring them fr m th first operator to other per onnel before placing
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detection and r duced risk of cont mination compared wi h swabs (classic or flocked) [41,42]. The
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for aspiration of hip joints, even with the aid of ultrasound guidance. In such cases, the instillation
and withdrawal of saline may improve the yield however leukocyte count cannot be performed on
specimens obtained through this approach [85].
The number of specimens obtained is critical for accurate diagnosis of peri-prosthetic and
implant-related infections. Between three and five tissues samples should be collected [4]. In a recent
study the collection of five tissue specimens was associated with the highest accuracy for diagnosis
of peri-prosthetic joint infection [86]. When homogenization and inoculation of tissue specimens
in blood culture bottles was performed, fewer samples (three tissues specimens) was adequate [51].
Other studies have suggested five samples should be collected, however this was dependent on the
type microorganisms and the site of infection [78–83,86]. Conversely, a larger number of samples
may also increase the risk of contamination [84]. The optimal number of specimens remains an
issue of controversy in the literature. Further studies including novel approaches such as molecular
methods, sterile collection procedures or new ways of sampling, are required to definitively address
this knowledge gap.
In conclusion, the diagnosis of prosthetic joint infection involves the cooperation between several
specialists. Current evidence has demonstrated improved patient outcomes when PJIs are managed
by a multidisciplinary team with established diagnosis and management algorithms [87]. Diagnostic
approaches aim to establish whether the joint is infected firstly, and then to define the involved
microorganism. These approaches should incorporate accurate clinical evaluation of the patient,
specific pre-operative investigations, such as inflammatory markers and, where indicated, synovial
fluid aspiration for microbiological diagnosis. The collection of multiple peri-prosthetic tissues is
important. In addition, processing of the implant using methods to dislodge the biofilm may also
assist with microorganism detection. Cultures should be always performed in an accredited clinical
microbiology laboratory and should include cultures for both aerobic and anaerobic organisms.
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